NetScientific is a transatlantic healthcare IP commercialisation group.
We fund and develop companies that significantly improve the health and well-being of people with chronic diseases.

OUR TEAM

Sector-specialist senior management team with extensive commercial experience.

  • Sir Richard Sykes, FRS

    Sir Richard Sykes, Non-Executive Chairman of the Group, joined NetScientific in 2008. Sir Richard spent thirty years working in the biotechnology and pharmaceutical industries, …

    Chairman
  • Ian Postlethwaite

    Ian Postlethwaite, Chief Executive Office, Chief Financial Officer & Company Secretary, joined NetScientific in June 2016. He brings over 14 years of biopharma experience …

    Chief Executive Officer, Chief Financial Officer & Company Secretary

NEWS

NetScientific plc (“NetScientific” or the “Company”)   Portfolio Company Glycotest Inc. receives the second  $3 million tranche of the $10 million Series A financing     London, UK …

NetScientific plc (“NetScientific” or the “Company”) Appointment to the Board   London, UK – 14 October 2019 – NetScientific plc (AIM: NSCI), the transatlantic healthcare IP commercialisation Group, …

NetScientific plc (“NetScientific” or the “Company”)   Portfolio Company PDS Biotechnology collaborates with Merck in Phase 2 studies for PDS0101 in metastatic head and neck cancer and high-risk …

NetScientific healthcare technology group